Gender | Age | Postmenopausal state
Item
female 50 years of age or older; post-menopausal (≥ 12 mo/ from last menstruation)
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
Left ventricular ejection fraction
Item
documented left ventricular ejection fraction (lvef) of 20-40% within 90 days prior to the baseline visit
boolean
C0428772 (UMLS CUI [1])
Heart failure Disease length | Heart failure Symptomatic Disease length New York Heart Association Classification
Item
history of hf for more than 90 days and a diagnosis of symptomatic hf (class iii nyha) for at least 30 days prior to the baseline visit
boolean
C0018801 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0018801 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C0872146 (UMLS CUI [2,3])
C1275491 (UMLS CUI [2,4])
Ambulatory | Able to walk Without Assistance
Item
ambulatory (i.e., able to walk without assistance of another person or device such as cane or walker)
boolean
C0439841 (UMLS CUI [1])
C2712089 (UMLS CUI [2,1])
C0332288 (UMLS CUI [2,2])
C1269765 (UMLS CUI [2,3])
Neuromuscular Diseases Distance of walking limitation | Rheumatism Distance of walking limitation
Item
neuromuscular or rheumatologic conditions that limit the to their ability to improve walking distance
boolean
C0027868 (UMLS CUI [1,1])
C2197730 (UMLS CUI [1,2])
C0035435 (UMLS CUI [2,1])
C2197730 (UMLS CUI [2,2])
Pulmonary Edema | Multiple Organ Failure | Shock, Cardiogenic
Item
pulmonary edema or multiorgan failure or cardiogenic shock within 30 days prior to the baseline visit
boolean
C0034063 (UMLS CUI [1])
C0026766 (UMLS CUI [2])
C0036980 (UMLS CUI [3])
Congenital heart disease | Cardiomyopathy Infiltrating
Item
congenital heart disease, infiltrative myocardial disease
boolean
C0152021 (UMLS CUI [1])
C0878544 (UMLS CUI [2,1])
C0332448 (UMLS CUI [2,2])
Angina, Unstable | Myocardial Infarction
Item
unstable angina or myocardial infarction within 30 days prior to the baseline visit
boolean
C0002965 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
Genital hemorrhage Abnormal Undiagnosed
Item
undiagnosed abnormal genital bleeding
boolean
C0854381 (UMLS CUI [1,1])
C0205161 (UMLS CUI [1,2])
C1408353 (UMLS CUI [1,3])
Breast Carcinoma | Operation on breast | Breast Diseases | Oestrogen therapy Contraindicated | Hormone Therapy Contraindicated
Item
history of breast cancer, breast surgery, or breast disease contraindicating estrogen/hormone therapy
boolean
C0678222 (UMLS CUI [1])
C3714726 (UMLS CUI [2])
C0006145 (UMLS CUI [3])
C0279494 (UMLS CUI [4,1])
C1444657 (UMLS CUI [4,2])
C0279025 (UMLS CUI [5,1])
C1444657 (UMLS CUI [5,2])
Polycystic Ovary Syndrome | Condition Adverse reaction to testosterone
Item
polycystic ovary syndrome or any other condition known to be adversely affected by testosterone treatment
boolean
C0032460 (UMLS CUI [1])
C0348080 (UMLS CUI [2,1])
C0570247 (UMLS CUI [2,2])
Resting Heart Rate
Item
resting heart rate > 120 bpm
boolean
C1821417 (UMLS CUI [1])
Systolic Pressure | Diastolic blood pressure
Item
systolic blood pressure > 180 mmhg or diastolic blood pressure > 100 mmhg
boolean
C0871470 (UMLS CUI [1])
C0428883 (UMLS CUI [2])
Allergy to adhesive | Allergy to adhesive Suspected | Hypersensitivity Testosterone Transdermal System Component | Hypersensitivity Suspected Testosterone Transdermal System Component
Item
known or suspected hypersensitivity or allergy to any adhesive or to any of the components of the testosterone transdermal system (tts)
boolean
C1635164 (UMLS CUI [1])
C1635164 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C4276340 (UMLS CUI [3,2])
C1705248 (UMLS CUI [3,3])
C0020517 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C4276340 (UMLS CUI [4,3])
C1705248 (UMLS CUI [4,4])
Selective Estrogen Receptor Modulators | Other Coding | Selective Progesterone Receptor Modulators | tibolone | Testosterone | Estrogens | Progesterone Agonists/Antagonists | Prescription Drugs | Drugs, Non-Prescription
Item
use of serms, sarms, sprms, tibolone, testosterone, estrogen, progesterone agonists and antagonists or taking any prescription and over the counter medications/
boolean
C0732611 (UMLS CUI [1])
C3846158 (UMLS CUI [2])
C3854078 (UMLS CUI [3])
C0076660 (UMLS CUI [4])
C0039601 (UMLS CUI [5])
C0014939 (UMLS CUI [6])
C4020604 (UMLS CUI [7])
C0304227 (UMLS CUI [8])
C0013231 (UMLS CUI [9])
Nutraceuticals Resulting in Anabolic Effect | Nutraceuticals Resulting in Steroid hormone Effect | Phytoestrogens
Item
nutraceuticals (eg, phyto-estrogens) that may have anabolic or steroid hormonal effects within 30 days prior to the baseline visit
boolean
C1518478 (UMLS CUI [1,1])
C0332294 (UMLS CUI [1,2])
C3179309 (UMLS CUI [1,3])
C1518478 (UMLS CUI [2,1])
C0332294 (UMLS CUI [2,2])
C0301818 (UMLS CUI [2,3])
C1280500 (UMLS CUI [2,4])
C0071011 (UMLS CUI [3])
Androgen therapy Oral | Androgen therapy Sublingual | Androgen therapy Topical | Androgen therapy Transdermal Injectable | Androgen therapy Vaginal | dehydroepiandrosterone
Item
use of marketed or investigational oral, sub-lingual, topical, transdermal injectable, or vaginal androgen therapy including dehydroepiandrosterone (dhea) at any time within 3 months prior to the baseline visit
boolean
C0279493 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0279493 (UMLS CUI [2,1])
C0001565 (UMLS CUI [2,2])
C0279493 (UMLS CUI [3,1])
C1522168 (UMLS CUI [3,2])
C0279493 (UMLS CUI [4,1])
C0040652 (UMLS CUI [4,2])
C0086466 (UMLS CUI [4,3])
C0279493 (UMLS CUI [5,1])
C1522570 (UMLS CUI [5,2])
C0011185 (UMLS CUI [6])
CORTICOSTEROIDS FOR SYSTEMIC USE
Item
use of systemic corticosteroids within 30 days prior to the baseline visit (acute use for fewer than 7 days is acceptable)
boolean
C3653708 (UMLS CUI [1])